Baron Silver Stevens Financial Advisors’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5
Closed -$1K 66
2020
Q4
$1K Buy
+5
New +$1.28K ﹤0.01% 428

Other funds holding AMED

Baron Silver Stevens Financial Advisors's AMED Position: Q1 2021 in Review

Baron Silver Stevens Financial Advisors sold out of Amedisys (AMED) in Q1 2021, closing a stake of 5 shares — an estimated $1K sold.

Baron Silver Stevens Financial Advisors first reported a position in AMED in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Baron Silver Stevens Financial Advisors reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Baron Silver Stevens Financial Advisors sold 5 Amedisys shares in Q1 2021, an estimated $1K.
  • Baron Silver Stevens Financial Advisors first reported a position in Amedisys in Q4 2020 and held it in 1 quarter.
  • Baron Silver Stevens Financial Advisors's Amedisys position peaked at $1K in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Baron Silver Stevens Financial Advisors's 13F filing for Q1 2021, filed 27 Apr 2021.